Gene · 9682
Papers1,858
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 1,858
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RETRACTED: KDM4A promotes the growth of non-small cell lung cancer by mediating the expression of Myc via DLX5 through the Wnt/β-catenin signaling pathway. | Life Sci | 2020 | 33002480 | PubTator, text mining | PubMed |
| Circular RNAs in gastrointestinal cancer: Current knowledge, biomarkers and targeted therapy (Review). | Int J Mol Med | 2020 | 33000182 | PubTator, text mining | PubMed |
| Human 2-oxoglutarate-dependent oxygenases: nutrient sensors, stress responders, and disease mediators. | Biochem Soc Trans | 2020 | 32985654 | PubTator, text mining | PubMed |
| Role of succinate dehydrogenase deficiency and oncometabolites in gastrointestinal stromal tumors. | World J Gastroenterol | 2020 | 32982110 | PubTator, text mining | PubMed |
| Chromatin-modifying drugs and metabolites in cell fate control. | Cell Prolif | 2020 | 32979011 | PubTator, text mining | PubMed |
| microRNA-216b enhances cisplatin-induced apoptosis in osteosarcoma MG63 and SaOS-2 cells by binding to JMJD2C and regulating the HIF1α/HES1 signaling axis. | J Exp Clin Cancer Res | 2020 | 32972441 | PubTator, text mining | PubMed |
| EFCC1 as a putative prognostic biomarker in lung adenocarcinoma. | Ann Transl Med | 2020 | 32953781 | PubTator, text mining | PubMed |
| A UHPLC-MS/MS method for the quantification of JIB-04 in rat plasma: Development, validation and application to pharmacokinetics study. | J Pharm Biomed Anal | 2020 | 32892084 | PubTator, text mining | PubMed |
| miR-137-3p Modulates the Progression of Prostate Cancer by Regulating the JNK3/EZH2 Axis. | Onco Targets Ther | 2020 | 32884286 | PubTator, text mining | PubMed |
| RFX5 promotes the progression of hepatocellular carcinoma through transcriptional activation of KDM4A. | Sci Rep | 2020 | 32883983 | PubTator, text mining | PubMed |
| Histone methyltransferase and drug resistance in cancers. | J Exp Clin Cancer Res | 2020 | 32859239 | PubTator, text mining | PubMed |
| Isocitrate Dehydrogenase Mutations in Myelodysplastic Syndromes and in Acute Myeloid Leukemias. | Cancers (Basel) | 2020 | 32859092 | PubTator, text mining | PubMed |
| Epithelial-Mesenchymal Transition and Metabolic Switching in Cancer: Lessons From Somatic Cell Reprogramming. | Front Cell Dev Biol | 2020 | 32850862 | PubTator, text mining | PubMed |
| Decoding the rosetta stone of mitonuclear communication. | Pharmacol Res | 2020 | 32846213 | PubTator, text mining | PubMed |
| Epigenetic effects of low-level sodium arsenite exposure on human liver HepaRG cells. | Arch Toxicol | 2020 | 32844245 | PubTator, text mining | PubMed |
| Estrogen Induces Selective Transcription of Caveolin1 Variants in Human Breast Cancer through Estrogen Responsive Element-Dependent Mechanisms. | Int J Mol Sci | 2020 | 32825330 | PubTator, text mining | PubMed |
| Histone H1 Post-Translational Modifications: Update and Future Perspectives. | Int J Mol Sci | 2020 | 32824860 | PubTator, text mining | PubMed |
| IDH1 Targeting as a New Potential Option for Intrahepatic Cholangiocarcinoma Treatment-Current State and Future Perspectives. | Molecules | 2020 | 32824685 | PubTator, text mining | PubMed |
| Suppressed "Warburg Effect" in Nasopharyngeal Carcinoma Via the Inhibition of Pyruvate Kinase Type M2-Mediated Energy Generation Pathway. | Technol Cancer Res Treat | 2020 | 32815467 | PubTator, text mining | PubMed |
| Association of JMJD2B and Hypoxia-Inducible Factor 1 Expressions with Poor Prognosis in Osteosarcoma. | Anal Cell Pathol (Amst) | 2020 | 32802732 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9682/papers?page=38